Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer
Public ClinicalTrials.gov record NCT00603863. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase Ib/II Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Patients With Previously Untreated Advanced Pancreatic Cancer.
Study identification
- NCT ID
- NCT00603863
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- IMMU-107 (hPAM4) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2007
- Primary completion
- Jun 30, 2013
- Completion
- Nov 30, 2013
- Last update posted
- Aug 15, 2021
2008 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Christiana Care Health Services | Newark | Delaware | 19718 | — |
| Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| Herbert Werthem College of Medicine/Jackson North Medical Center | Miami | Florida | 33169 | — |
| Moffit Cancer Center | Tampa | Florida | 33612 | — |
| Winship Cancer Institute/Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Goshen Cancer Center | Goshen | Indiana | 46526 | — |
| New York Presbyterian Hospital/Weill Cornell Medical Center | New York | New York | 10021 | — |
| Mt. Sinai Medical Center | New York | New York | 10029 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Thomas Jefferson University Medical Center | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00603863, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2021 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00603863 live on ClinicalTrials.gov.